Malvern, PA, United States of America

Zhi Wang

This inventor holds 1 USPTO granted patent. Top assignee: Wyeth. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhi Wang. Retrieved from https://idiyas.com/inventor/zhi-wang-fn8qlo60

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhi Wang: Innovator in Therapeutic Treatments

Introduction

Zhi Wang is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of therapeutic treatments, particularly in relation to the 5-HT6 receptor. His work has the potential to impact various disorders that are influenced by this receptor.

Latest Patents

Zhi Wang holds a patent for "Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands." This invention provides a compound of formula I and outlines its use for the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor. This patent highlights his innovative approach to addressing complex medical challenges.

Career Highlights

Zhi Wang is currently employed at Wyeth, a company known for its commitment to advancing healthcare solutions. His role at Wyeth allows him to collaborate with other talented professionals in the field.

Collaborations

Some of his coworkers include Youchu Wang and Chia-Cheng Shaw. Their collective expertise contributes to the innovative environment at Wyeth.

Conclusion

Zhi Wang's contributions to the field of therapeutic treatments through his patent and work at Wyeth exemplify his dedication to innovation. His research holds promise for improving the lives of individuals affected by disorders related to the 5-HT6 receptor.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…